Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
14.39
-0.27 (-1.84%)
At close: Aug 13, 2026, 4:00 PM EDT
14.30
-0.09 (-0.63%)
Pre-market: Aug 14, 2026, 8:25 AM EDT
Design Therapeutics Market Cap
Design Therapeutics has a market cap or net worth of $900.55 million as of August 14, 2026. Its market cap has increased by 217.54% in one year.
Market Cap
900.55M
Enterprise Value
695.82M
1-Year Change
217.54%
Ranking
Category
Stock Price
$14.39
ChartMarket Cap Chart
Since the IPO on March 26, 2021, Design Therapeutics's market cap has decreased from $2.21B to $900.55M, a decrease of -59.18%. That is a compound annual growth rate of -15.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 900.55M | 68.54% |
| Dec 31, 2025 | 534.32M | 52.95% |
| Dec 31, 2024 | 349.35M | 135.41% |
| Dec 29, 2023 | 148.40M | -74.10% |
| Dec 30, 2022 | 572.92M | -51.55% |
| Dec 31, 2021 | 1.18B | -46.40% |
| Mar 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Geron | 1.01B |
| Omeros | 992.27M |
| Ardelyx | 989.27M |
| Solid Biosciences | 972.00M |
| Olema Pharmaceuticals | 913.48M |
| Arbutus Biopharma | 906.70M |
| Kura Oncology | 882.42M |
| Theravance Biopharma | 878.47M |